Here's a quick overview of Raffles Medical Group Ltd's (SGX: BSL) historical performance for the last five years.

In the second part of this two part series, we focus on highlighting four more small/mid cap gems that have the potential to become winners in the near future. Investors Takeaway: 4 Small/Mid Cap Winners In The Making Sunpower Group Source: Sunpower Group Sunpower Group (Sunpower) is worth paying attention to. A one-stop solution provider for energy conservation, waste-to-energy and renewable energy projects, Sunpower specializes in the design, R&D, and manufacture of energy conservation products in China. Green Investment Sunpower recorded a strong core net profit growth of 117.5 percent year-on-year, thanks to a strong green investment segment. Its manufacturing revenue also grew by around 40 percent to underpin an improvement in gross margin and operating cash flow. Moving forwa

We're examining Raffles Medical Group Ltd’s (SGX: BSL) management's thoughts on its latest performance and future growth.

DBS Group Holdings Ltd (SGX: D05), Oversea-Chinese Banking Corporation Limited (SGX: O39), and Raffles Medical Group Ltd (SGX: BSL) are three companies to hold for the long-term.

Despite all the good things to like about Raffles Medical Group Ltd (SGX: BSL), here’s one thing not to like about the company now.

I writing a topical email every week to my mailing list. Here’s our last email to subscribers which I thought I share. You can sign up on our mailing list to get the latest updates when it goes out every week.   I’ve just finished a short two-week stint on an executive program at Cambridge for real estate. I head back every couple of months to keep up to date with the latest happenings of the industry and to learn from the expertise of other real estate professionals. Plenty of posts upcoming that will cover some of the key learning points which I think are relevant to investors are on the way. I’ve been talking a lot about bonds and Hyflux over the last few months so I thought I talk about the REIT market. S-REITs in aggregate have delivered robust performance over the

We will look at five reasons why Raffles Medical Group Ltd (SGX: BSL) may qualify as good investment candidate.

We will look at three reasons why Raffles Medical Group Ltd (SGX: BSL) may qualify as good investment candidate.

Raffles Medical Group Ltd (SGX:BSL) and Singapore O&G Ltd (SGX:1D8) are both healthcare stocks. Which is the better buy right now?

By now, you should already have heard of the news that each Singaporean will receive up to $300 from the government from the one-off BiCentennial Bonus. While most attention goes to the one-off BiCentennial Bonus for Singaporeans, there are much more takeaways form this year’s Budget, especially if you are an investor. Here are four key investment takeaways from this year’s Budget to help you position your portfolio for long term investments. Investors Takeaway: 4 Investment Takeaways From SG Budget 2019 More Spending On Healthcare To Tackle Ageing Population Perhaps, the biggest talking point of this Budget (other than the timing of GST hike) is the increase in healthcare spending. A few initiatives were announced in this year’s Budget to help Singaporeans manage healthcare cost

Raffles Medical Group Ltd (SGX:BSL) and Sheng Siong Group Ltd (SGX:OV8) saw their profits grow in 2018.

We will have an overview of the positive and negatives factors from Raffles Group Ltd’s(SGX: BSL) latest result.

The integrated healthcare provider reported a steady set of earnings along with an increase in final dividends.

On 18 February 2019, Finance Minister Heng Swee Keat delivered the Singapore Budget 2019 in Parliament. In the largely expansionary budget for the year, the main highlights were the Bicentennial Bonus, details on the Merdeka Generation Package, expansion in the scope of public spending on healthcare via CHAS, and maintaining a high rate of spending on defence. Read Also: Singapore Budget 2019: Here Are 4 Of The Most Important Announcements That Affect All Of Us In this edition of our 4 Stocks This Week column, we can’t look any further than the stocks that will benefit the most from the Singapore Budget 2019. # 1 ST Engineering (SGX: S63) During the Singapore Budget 2019, one of the first things Minister Heng spoke about was the need for our country to stay vigilant to the threats around

You give some people whose job is to invest money, and by a lot of standards they are good at it.  Shockingly only 49% of their picks made money. Some of them was successful only 30% of the time.  At the end of these, almost non of them lost money. They still made a lot of money out of it.  I think this was the part of the article that caught my attention.  The main reason is that it is something that is not often explain in a book, or by course trainers, or in video how to navigate this problem.  A lot of the stocks that you come across will look like they are the best picks.  Some of these, you didn’t do the prospecting yourself. You followed someone you assessed as an astute investor (and correctly so by all measure), yet after 5 years, your results l

According to Investopedia, a defensive stock is a stock that is able to provide a consistent dividend and retain stable earnings regardless of the market condition. Due to a regular demand for their products and services, these stocks tend to remain relatively stable even during a market downturn. Conversely, they tend to underperform the market during times of economic expansion. For this week’s column, we feature 4 defensive stocks listed on SGX and how they fared for the past year. Read Also: How To Diversify Your Investment Portfolio Outside Of Singapore M1 Limited (SGX: B2F) M1 Limited is one of the major telecommunications companies providing mobile and fixed services to consumers and corporate customers in Singapore. As of 30 September 2018, M1 has around 1.36 million postpaid cus

Raffles Medical Group Ltd’s (SGX: BSL) widely-anticipated hospital in Chongqing, China, has opened.

I am not planning to sell my shares of Raffles Medical Group Ltd (SGX: BSL) despite its recent share price decline.

I was at my favourite book store browsing for interesting reads with a friend when we started talking about investing. She asked, “What exactly is value investing?” After I explained the concept – which in essence is buying a dollar for fifty cents – she commented: “It seems like the hardest part about investing is determining what the value of a company is.” Realisation That’s when it dawned on me: Not many may be aware that the hardest thing about investing isn’t learning how to interpret financial statements and work out the value of a company. The hardest thing is having the discipline to stay the course. You see, it’s one thing to know that patience and time is needed for an investment to work. It’s another thing to hold onto your shares when you’re d

Since the start of 2018, Singapore Medical Group has caught the attention of Shares Investment with its strong growth. However, despite another splendid quarter this earnings season, the stock continues to trail lower. At the time of writing, the stock of Singmedical had shed almost another 10 percent to trade at $0.40 per share, falling from $0.44 when we last reviewed the stock in August. Yet, amidst the negative share price performance, value seekers who believe that the long-term is a weighing machine should – in our view – continue accumulating or holding onto the stock. We reviewed the latest 3Q18 results and offer readers these reasons to maintain a contrarian view of the stock. Earnings Review Singmedical continues to be firing on all cylinders. For the latest quarter, revenue